Replies to post #46066 on 22nd Century Group Inc (XXII)

[nonameface13]

Well, Henry did suggest that people are expecting to hear back from the FDA on the Standard by end of December. With regard to ANPRM, Gottlieb said:

"We have expedited the review of many of the comments, and spent hours, days and months taking close consideration of the questions raised and evidence presented by the public and various stakeholders."

That sounds to me like we may hear something by end of December as well. In any case, the next 60 days are setup to be interesting. Causal density is high IMO and we can only surmise what'll move XXII at this point in its company timeline.